Singapore markets closed
Straits Times Index
3,280.10 -7.65 (-0.23%) Nikkei
37,934.76 +306.28 (+0.81%) Hang Seng
17,651.15 +366.61 (+2.12%) FTSE 100
8,132.28 +53.42 (+0.66%) Bitcoin USD
64,358.51 +834.00 (+1.31%) CMC Crypto 200
1,337.69 -58.85 (-4.21%)
GILD Jan 2025 95.000 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:27PM EDT. Market open.
| Previous close | 11.47 |
| Open | 11.47 |
| Bid | 21.95 |
| Ask | 24.80 |
| Strike | 95.00 |
| Expiry date | 2025-01-17 |
| Day's range | 11.47 - 11.47 |
| Contract range | N/A |
| Volume | |
| Open interest | 39 |
- Thomson Reuters StreetEvents
Q1 2024 Gilead Sciences Inc Earnings Call
Q1 2024 Gilead Sciences Inc Earnings Call
Business WireFDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
FOSTER CITY, Calif., April 26, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) to treat pregnant people with HIV-1 (PWH) with suppressed viral loads. These additional data stem from Study 5310, which evaluated the pharmacokinetics, safety and efficacy of
- GuruFocus.com
Gilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
Explore Gilead's latest financial performance and strategic directions, including updates on HIV, oncology, and liver disease segments.
© 2024 Yahoo. All rights reserved.